• Episode 369: Paper of the Month with Bishoy Faltas
    Nov 25 2024

    Bishoy joins us to discuss his work on extrachromosomal DNA in bladder cancer from his latest Nature publication

    Show more Show less
    46 mins
  • Episode 368: Radiomics in RCC: Live from IKCS
    Nov 19 2024

    Andrew Smith from St. Jude's joins us to discuss the emerging field of radiomics and shares his hopes and skepticism

    Show more Show less
    37 mins
  • Episode 367: Abiraterone vs AR inhibitors (Fanta vs Coke) in Prostate Cancer
    Nov 11 2024

    Chuck Ryan from MSKCC joins to talk about various aspects of AR inhibition in prostate cancer and relative benefits and risks.

    Show more Show less
    57 mins
  • Episode 366: ARPIs in Prostate Cancer - Are They Different?
    Nov 4 2024

    Chris Sweeney and Rob Jones join Brian and Tom to discuss the relative merits of different ARPIs in prostate cancer.

    Show more Show less
    32 mins
  • Episode 365: A Review of the Advanced Prostate Cancer Consensus Conference (APCCC)
    Oct 28 2024

    Episode 365: Silke Gillessen and Betrand Tombal join the show to discuss the APCCC meeting and recent publication.

    Show more Show less
    48 mins
  • Episode 364: 腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜
    Oct 24 2024

    腎がんの最新の話題〜IO rechallengeと乳頭型腎がんの治療戦略〜

    Show more Show less
    16 mins
  • Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
    Oct 24 2024

    前立腺がんの最新の話題〜T cell directed therapyとradioligands〜

    Show more Show less
    14 mins
  • Episode 362: 膀胱がんの最新の話題〜周術期薬物療法とADC〜
    Oct 24 2024

    膀胱がんの最新の話題〜周術期薬物療法とADC〜

    Show more Show less
    13 mins